# | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | Atreleuton | 18 | CLint | < | 3 | microL/min/1E6 cells | ALA3301371 | uL.min-1.(10^6cells)-1 | ||||
2. | Atreleuton | 18 | pIC50 | < | 4.7 | ALA4651403 | No. Measurements = 1 | nM | Severe acute respiratory syndrome coronavirus 2 | |||
3. | Atreleuton | 18 | IC50 | > | 0 | M | ALA4651403 | No. Measurements = 1 | nM | Severe acute respiratory syndrome coronavirus 2 | ||
4. | Atreleuton | 18 | solubility | = | 30 | uM | ALA4730528 | nM | ||||
5. | Atreleuton | 18 | Stabilty | = | 47 | % | ALA4730527 | % | ||||
6. | Atreleuton | 18 | IC50 | = | 0.09 | uM | ALA4730524 | 7.05 | nM | Homo sapiens | ||
7. | Atreleuton | 18 | IC50 | = | 2.7 | uM | ALA4730523 | 5.57 | nM | Homo sapiens | ||
8. | Atreleuton | 18 | INH | = | 80 | % | ALA4351250 | % | Homo sapiens | |||
9. | Atreleuton | 18 | Inhibition | = | 4 | % | ALA785139 | % | Rattus norvegicus | |||
10. | Atreleuton | 18 | T1/2 | = | 15 | hr | ALA633211 | hr | ||||
11. | Atreleuton | 18 | GT rate | < | 0.01 | nM min-1 (mg of protein)-1 | ALA633121 | nM min-1 (mg of protein)-1 | ||||
12. | Atreleuton | 18 | ED50 | = | 2.8 | mg kg-1 | ALA785091 | mg.kg-1 | Rattus norvegicus | |||
13. | Atreleuton | 18 | IC50 | = | 0.16 | uM | ALA701321 | 6.80 | nM | Homo sapiens | ||
14. | Atreleuton | 18 | IC50 | = | 160 | nM | ALA619883 | 6.80 | nM | Homo sapiens | ||
15. | Atreleuton | 18 | IC50 | = | 23 | nM | ALA619225 | 7.64 | nM | Rattus norvegicus | ||
16. | Atreleuton | 18 | F | = | 90 | % | ALA631958 | % | ||||
17. | Atreleuton | 18 | F | = | 95 | % | ALA631959 | % | ||||
18. | Atreleuton | 18 | F | = | 90 | % | ALA629642 | % | ||||
19. | Atreleuton | 18 | F | = | 100 | % | ALA629644 | % | ||||
20. | Atreleuton | 18 | F | = | 60 | % | ALA629645 | % |